SMS Pharmaceuticals is currently trading at Rs. 250.05, up by 11.00 points or 4.60% from its previous closing of Rs. 239.05 on the BSE.

The scrip opened at Rs. 254.85 and has touched a high and low of Rs. 258.35 and Rs. 249.10 respectively. So far 17972 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 398.00 on 23-Sep-2024 and a 52 week low of Rs. 175.00 on 07-Apr-2025.

Last one week high and low of the scrip stood at Rs. 258.35 and Rs. 229.55 respectively. The current market cap of the company is Rs. 2220.73 crore.

The promoters holding in the company stood at 66.26%, while Institutions and Non-Institutions held 2.51% and 31.22% respectively.

United States Food and Drug Administration (USFDA) has concluded inspection at SMS Pharmaceuticals’ Central Laboratory Analytical Services, located at Hyderabad, Telangana. The inspection, conducted from June 23, 2025 to June 25, 2025, concluded with zero Form 483 observations. 

The Company is committed to meeting the highest quality standards and is further committed to full compliance with CGMP & GLP regulations at all its manufacturing & Analytical facilities. The Central Laboratory Analytical Services is company’s independent testing laboratory, and this was the second successful USFDA inspection for the facility.

SMS Pharmaceuticals is a diversified and integrated pharmaceutical company specialising in API and intermediates for global customers.